Crescent Capital BDC, Inc. (CCAP)

Over the past six months, Crescent Capital BDC's stock price has decreased. As of November 18, 2025, the share price was $13.33, a 30.28% decrease from $19.12 on November 19, 2024. For the third quarter of 2025, CCAP reported net investment income of $0.46 per share, slightly below the estimated $0.48, and total investment income of $41.4 million, falling short of the $43.1 million estimate; the company declared a fourth-quarter regular cash dividend of $0.42 per share, payable in January 2026. Net Asset Value (NAV) per share decreased to $19.28 as of September 30, 2025, from $19.55 at the end of the previous quarter. In the second quarter of 2025, net investment income was $0.46 per share, an increase from $0.45 per share in the first quarter, and the company maintained 110% base dividend coverage for the quarter. Analyst recommendations in early November 2025 included "Outperform" ratings from Keefe, Bruyette & Woods and Oppenheimer, and an "Equal-Weight" recommendation from Wells Fargo. MarketBeat's MarketRank™ scored Crescent Capital BDC higher than 90% of companies evaluated in the finance sector.

There is no explicit information available regarding demand seasonality for Crescent Capital BDC, Inc.'s products and services. As a business development company providing financing solutions to private middle-market companies, the demand for its capital solutions may not exhibit strong seasonal patterns.

Crescent Capital BDC, Inc. (CCAP) is a specialty finance company that operates as an externally managed, closed-end, non-diversified business development company (BDC). The company aims to maximize total return for stockholders through current income and capital appreciation by investing in the debt of private middle-market companies, primarily in the United States. It provides flexible financing solutions across various industries, including healthcare, business services, consumer products, and industrials, offering secured debt, unsecured debt, and related equity securities.

Crescent Capital BDC, Inc. primarily focuses its investments on private middle-market companies located in the United States. While its core investment activity is domestic, the company also has some investments in Europe and Australia, representing 10% and 2% of its investments, respectively. Crescent Capital Group, which externally manages Crescent Capital BDC, is headquartered in Los Angeles, with additional offices in New York, Boston, Chicago, and London.

Crescent Capital BDC acknowledged the risk of damage to its brand and reputation if it fails to act responsibly in areas such as diversity, equity and inclusion, environmental stewardship, support for local communities, corporate governance, transparency, and considering ESG factors in its investment processes. Adverse incidents related to ESG activities could impact the value of its brand, relationships with portfolio companies, operational costs, and investor relations. No specific events negatively impacting its reputation in the past year were found in the provided search results.

Crescent Capital BDC (CCAP) has a diverse ownership structure, with approximately 23.93% of its stock owned by institutional investors, 9.92% by insiders, and 3.87% by public companies and individual investors. Major institutional owners include Texas County & District Retirement System, Blackstone Inc., Sun Life Financial Inc., Franklin Resources Inc., and Ares Management LLC. Other significant institutional holders include Fidelity National Financial, Inc., Putnam ETF Trust - Putnam BDC ETF -, Mariner, LLC, Bulldog Investors, LLP, and CF Capital LLC.